首页 > 最新文献

Oman Journal of Ophthalmology最新文献

英文 中文
"Headlight in the fog" fundus appearance: Is just a sign and not a conclusion. "雾中车灯 "眼底外观:只是一种征兆,而不是结论。
Q3 Medicine Pub Date : 2024-10-24 eCollection Date: 2024-09-01 DOI: 10.4103/ojo.ojo_204_23
Krushna Gopal Panda, Anup Kelgaonkar
{"title":"\"Headlight in the fog\" fundus appearance: Is just a sign and not a conclusion.","authors":"Krushna Gopal Panda, Anup Kelgaonkar","doi":"10.4103/ojo.ojo_204_23","DOIUrl":"10.4103/ojo.ojo_204_23","url":null,"abstract":"","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 3","pages":"405-407"},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620317/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142801301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing the sedative and analgesic effects of ketorolac and diclofenac eye drops among patients with cataract surgery: A double-blind randomized clinical trial.
Q3 Medicine Pub Date : 2024-10-24 eCollection Date: 2024-09-01 DOI: 10.4103/ojo.ojo_246_23
Hesameddin Modir, Esmail Moshiri, Alireza Amani, Amirreza Modir

Aim: The aim of this study was to compare the sedative and analgesic effects of ketorolac and diclofenac eye drops among patients with cataract surgery (CS) who received tetracaine.

Methods: This double-blind randomized clinical trial was conducted in 2022. Participants were the candidates for CS consecutively selected from Amirkabir hospital, Arak, Iran, and were assigned to an artificial tear group, a ketorolac group, and a diclofenac group through block randomization. Pain, sedation status, heart rate, blood pressure, and arterial oxygen saturation were assessed during and after surgery. Complications prevalence and intraoperative propofol use were also documented. Data were analyzed using the SPSS software (v. 20.0) at a significance level of <0.05.

Results: There were no significant differences among the study groups respecting participants' age, gender, body mass index, blood pressure, heart rate, arterial oxygen saturation, CS duration, and Aldrete score (P > 0.05). From 5 min after CS onward, the mean score of pain in the ketorolac group was significantly less than the other groups (P < 0.05). The mean score of sedation from recovery to 1 h after surgery in the artificial tear group was significantly more than the other groups, whereas the mean score of sedation 2 and 4 h after CS in the ketorolac group was significantly more than the other groups (P < 0.05). Propofol use in the artificial tear group was significantly more than in other groups (P = 0.001) and patient and surgeon satisfaction in this group was significantly less than in other groups (P < 0.05). The ketorolac and the diclofenac groups did not significantly differ from each other respecting surgeon and patient satisfaction and the prevalence of complications (P > 0.05).

Conclusion: Ketorolac eye drops are more effective than diclofenac eye drops in significantly reducing intraoperative pain among the candidates for CS with topical anesthesia. Therefore, ketorolac eye drops can be used with tetracaine eye drops in CS with topical anesthesia to produce greater perioperative analgesia and sedation.

{"title":"Comparing the sedative and analgesic effects of ketorolac and diclofenac eye drops among patients with cataract surgery: A double-blind randomized clinical trial.","authors":"Hesameddin Modir, Esmail Moshiri, Alireza Amani, Amirreza Modir","doi":"10.4103/ojo.ojo_246_23","DOIUrl":"10.4103/ojo.ojo_246_23","url":null,"abstract":"<p><strong>Aim: </strong>The aim of this study was to compare the sedative and analgesic effects of ketorolac and diclofenac eye drops among patients with cataract surgery (CS) who received tetracaine.</p><p><strong>Methods: </strong>This double-blind randomized clinical trial was conducted in 2022. Participants were the candidates for CS consecutively selected from Amirkabir hospital, Arak, Iran, and were assigned to an artificial tear group, a ketorolac group, and a diclofenac group through block randomization. Pain, sedation status, heart rate, blood pressure, and arterial oxygen saturation were assessed during and after surgery. Complications prevalence and intraoperative propofol use were also documented. Data were analyzed using the SPSS software (v. 20.0) at a significance level of <0.05.</p><p><strong>Results: </strong>There were no significant differences among the study groups respecting participants' age, gender, body mass index, blood pressure, heart rate, arterial oxygen saturation, CS duration, and Aldrete score (<i>P</i> > 0.05). From 5 min after CS onward, the mean score of pain in the ketorolac group was significantly less than the other groups (<i>P</i> < 0.05). The mean score of sedation from recovery to 1 h after surgery in the artificial tear group was significantly more than the other groups, whereas the mean score of sedation 2 and 4 h after CS in the ketorolac group was significantly more than the other groups (<i>P</i> < 0.05). Propofol use in the artificial tear group was significantly more than in other groups (<i>P</i> = 0.001) and patient and surgeon satisfaction in this group was significantly less than in other groups (<i>P</i> < 0.05). The ketorolac and the diclofenac groups did not significantly differ from each other respecting surgeon and patient satisfaction and the prevalence of complications (<i>P</i> > 0.05).</p><p><strong>Conclusion: </strong>Ketorolac eye drops are more effective than diclofenac eye drops in significantly reducing intraoperative pain among the candidates for CS with topical anesthesia. Therefore, ketorolac eye drops can be used with tetracaine eye drops in CS with topical anesthesia to produce greater perioperative analgesia and sedation.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 3","pages":"342-347"},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620299/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142801689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Foveal adhesion of a dexamethasone implant: Evaluation and follow-up via multimodal imaging.
Q3 Medicine Pub Date : 2024-10-24 eCollection Date: 2024-09-01 DOI: 10.4103/ojo.ojo_297_23
Ewelina Niedzwiecka, Julio Cesar Molina Martín, Juan García Sánchez, Violeta Martínez Torres, Encarnación Mengual Verdú
{"title":"Foveal adhesion of a dexamethasone implant: Evaluation and follow-up via multimodal imaging.","authors":"Ewelina Niedzwiecka, Julio Cesar Molina Martín, Juan García Sánchez, Violeta Martínez Torres, Encarnación Mengual Verdú","doi":"10.4103/ojo.ojo_297_23","DOIUrl":"10.4103/ojo.ojo_297_23","url":null,"abstract":"","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 3","pages":"411-412"},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620308/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142801886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Before blaming severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as trigger of new-onset ocular myasthenia, alternative etiologies must be ruled out.
Q3 Medicine Pub Date : 2024-10-24 eCollection Date: 2024-09-01 DOI: 10.4103/ojo.ojo_86_23
Josef Finsterer
{"title":"Before blaming severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as trigger of new-onset ocular myasthenia, alternative etiologies must be ruled out.","authors":"Josef Finsterer","doi":"10.4103/ojo.ojo_86_23","DOIUrl":"10.4103/ojo.ojo_86_23","url":null,"abstract":"","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 3","pages":"416-417"},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620309/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142801306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Branch retinal artery occlusion in a young patient with Mayer-Rokitansky-Küster-Hauser type 2 syndrome. 一名患有 Mayer-Rokitansky-Küster-Hauser 2 型综合征的年轻患者视网膜分支动脉闭塞。
Q3 Medicine Pub Date : 2024-10-24 eCollection Date: 2024-09-01 DOI: 10.4103/ojo.ojo_48_24
Anita Bedwal, Mousumi Banerjee, Parveen Rewri

Retinal vascular occlusions are rare in young people, and any occlusion warrants an extensive clinical evaluation to establish the etiology. Cardiac malformations are a source of embolism. We present a case of atrial septal defect (ASD) in a patient with type II Mayer-Rokitansky-Küster-Hauser syndrome, leading to unilateral branch retinal arterial occlusion (BRAO) in a young woman. A 21-year-old woman presented with sudden, painless, blurring of vision, and a superior visual field defect in her right eye. A fundus examination confirmed the BRAO diagnosis. Ocular and systemic evaluation revealed primary amenorrhea, ASD, ectopic kidneys, and pelvic cyst. Any vascular occlusion in a young patient must be thoroughly evaluated, including a detailed systemic history.

视网膜血管闭塞在年轻人中很少见,任何闭塞都需要进行广泛的临床评估以确定病因。心脏畸形是栓塞的来源之一。我们介绍了一例患有心房间隔缺损(ASD)的 II 型 Mayer-Rokitansky-Küster-Hauser 综合征患者,该病导致一名年轻女性出现单侧视网膜分支动脉闭塞(BRAO)。一名 21 岁女性患者突然出现无痛性视力模糊和右眼上视野缺损。眼底检查确诊为 BRAO。眼部和全身评估显示她患有原发性闭经、ASD、异位肾脏和盆腔囊肿。必须对年轻患者的任何血管闭塞进行彻底评估,包括详细的系统病史。
{"title":"Branch retinal artery occlusion in a young patient with Mayer-Rokitansky-Küster-Hauser type 2 syndrome.","authors":"Anita Bedwal, Mousumi Banerjee, Parveen Rewri","doi":"10.4103/ojo.ojo_48_24","DOIUrl":"10.4103/ojo.ojo_48_24","url":null,"abstract":"<p><p>Retinal vascular occlusions are rare in young people, and any occlusion warrants an extensive clinical evaluation to establish the etiology. Cardiac malformations are a source of embolism. We present a case of atrial septal defect (ASD) in a patient with type II Mayer-Rokitansky-Küster-Hauser syndrome, leading to unilateral branch retinal arterial occlusion (BRAO) in a young woman. A 21-year-old woman presented with sudden, painless, blurring of vision, and a superior visual field defect in her right eye. A fundus examination confirmed the BRAO diagnosis. Ocular and systemic evaluation revealed primary amenorrhea, ASD, ectopic kidneys, and pelvic cyst. Any vascular occlusion in a young patient must be thoroughly evaluated, including a detailed systemic history.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 3","pages":"393-395"},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620319/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142801404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation of optic nerve on magnetic resonance imaging with visual acuity in children with cerebral visual impairment.
Q3 Medicine Pub Date : 2024-10-24 eCollection Date: 2024-09-01 DOI: 10.4103/ojo.ojo_238_23
Veenish Samvedya, K S Smitha, Kamate Mahesh, Hattiholi Virupaxi

Aim: The aim of the study was to correlate the optic nerve dimensions at various locations on magnetic resonance imaging (MRI) with the visual acuity of children with cerebral visual impairment (CVI).

Materials and methods: A 1-year cross-sectional study was conducted in a tertiary care hospital involving 60 children aged 1 to 12 years diagnosed with CVI but without ocular pathologies. Visual acuity was evaluated using teller acuity cards (TACs). MRI of the brain and orbit was performed using three-dimensional high-resolution, volumetric heavily T2-weighted sequences to screen for brain pathologies and measure optic nerve dimensions at two locations. The correlation between visual acuity and optic nerve dimensions was analyzed. The Chi-square test was employed to assess significance using SPSS software.

Results: In our study, 64% (n = 38) of the participants were children under 3 years of age. The severity and characteristics of CVI influenced visual functioning at different ages. As children with CVI grew older and moved from Phase I to Phase III, the proportion with very low visual acuity significantly decreased from 85.2% in Phase I to 22.2% in Phase III and from 63.2% in the <3-year age group to 18.2% in more than 5-year age group. No direct correlation was found between optic nerve dimensions and visual acuity but optic disc changes such as optic disc pallor significantly correlated with low visual acuity.

Conclusion: Our findings suggest that there may not be a direct correlation between optic nerve dimensions and visual acuity in children with CVI. However, optic disc changes do correlate with visual acuity, but optic disc changes alone are not a criterion for assessing visual function. Additionally, our study highlights the significance of a combined assessment by a neuro- ophthalmologist and neuro-pedaitrician in children with CVI.

{"title":"Correlation of optic nerve on magnetic resonance imaging with visual acuity in children with cerebral visual impairment.","authors":"Veenish Samvedya, K S Smitha, Kamate Mahesh, Hattiholi Virupaxi","doi":"10.4103/ojo.ojo_238_23","DOIUrl":"10.4103/ojo.ojo_238_23","url":null,"abstract":"<p><strong>Aim: </strong>The aim of the study was to correlate the optic nerve dimensions at various locations on magnetic resonance imaging (MRI) with the visual acuity of children with cerebral visual impairment (CVI).</p><p><strong>Materials and methods: </strong>A 1-year cross-sectional study was conducted in a tertiary care hospital involving 60 children aged 1 to 12 years diagnosed with CVI but without ocular pathologies. Visual acuity was evaluated using teller acuity cards (TACs). MRI of the brain and orbit was performed using three-dimensional high-resolution, volumetric heavily T2-weighted sequences to screen for brain pathologies and measure optic nerve dimensions at two locations. The correlation between visual acuity and optic nerve dimensions was analyzed. The Chi-square test was employed to assess significance using SPSS software.</p><p><strong>Results: </strong>In our study, 64% (<i>n</i> = 38) of the participants were children under 3 years of age. The severity and characteristics of CVI influenced visual functioning at different ages. As children with CVI grew older and moved from Phase I to Phase III, the proportion with very low visual acuity significantly decreased from 85.2% in Phase I to 22.2% in Phase III and from 63.2% in the <3-year age group to 18.2% in more than 5-year age group. No direct correlation was found between optic nerve dimensions and visual acuity but optic disc changes such as optic disc pallor significantly correlated with low visual acuity.</p><p><strong>Conclusion: </strong>Our findings suggest that there may not be a direct correlation between optic nerve dimensions and visual acuity in children with CVI. However, optic disc changes do correlate with visual acuity, but optic disc changes alone are not a criterion for assessing visual function. Additionally, our study highlights the significance of a combined assessment by a neuro- ophthalmologist and neuro-pedaitrician in children with CVI.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 3","pages":"371-375"},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620311/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142801782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early visual and clinical outcomes of transepithelial photorefractive keratectomy versus transepithelial keratectomy with smart pulse technology for myopia.
Q3 Medicine Pub Date : 2024-10-24 eCollection Date: 2024-09-01 DOI: 10.4103/ojo.ojo_212_23
Turad Alkadi, Samar Alanazi, Abdulrahman Algwaiz, Salman Alyahya, Faris Binyousef

Purpose: The purpose of this study was to compare early visual outcomes, epithelial healing, and stromal haze between transepithelial photorefractive keratectomy (Trans-PRK) using smart pulse technology (SPT) with traditional Trans-PRK.

Methodology: This study is a retrospective, comparative study conducted at a private eye center in "Riyadh, Saudi Arabia," investigating myopic patients who underwent either Trans-PRK with SPT (study group) or traditional Trans-PRK (control group). The patients were assessed preoperatively and followed up at 1 week and 2 months postoperatively. The main outcomes included uncorrected distance visual acuity (UDVA), corneal haze, and corneal epithelial defect.

Results: This study included 501 eyes, of them, 222 eyes (44.3%) underwent Trans-PRK with SPT. The UDVA in the study group was significantly better 1 week postoperatively (P < 0.05). For the 2-month follow-up visits, there was no significant difference between the groups. Epithelium healing and stromal haze were comparable in the two groups without significant differences between them.

Conclusion: Transepithelial photorefractive keratectomy with SPT yielded better short-term visual outcomes than traditional Transepithelial photorefractive keratectomy.

{"title":"Early visual and clinical outcomes of transepithelial photorefractive keratectomy versus transepithelial keratectomy with smart pulse technology for myopia.","authors":"Turad Alkadi, Samar Alanazi, Abdulrahman Algwaiz, Salman Alyahya, Faris Binyousef","doi":"10.4103/ojo.ojo_212_23","DOIUrl":"10.4103/ojo.ojo_212_23","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to compare early visual outcomes, epithelial healing, and stromal haze between transepithelial photorefractive keratectomy (Trans-PRK) using smart pulse technology (SPT) with traditional Trans-PRK.</p><p><strong>Methodology: </strong>This study is a retrospective, comparative study conducted at a private eye center in \"Riyadh, Saudi Arabia,\" investigating myopic patients who underwent either Trans-PRK with SPT (study group) or traditional Trans-PRK (control group). The patients were assessed preoperatively and followed up at 1 week and 2 months postoperatively. The main outcomes included uncorrected distance visual acuity (UDVA), corneal haze, and corneal epithelial defect.</p><p><strong>Results: </strong>This study included 501 eyes, of them, 222 eyes (44.3%) underwent Trans-PRK with SPT. The UDVA in the study group was significantly better 1 week postoperatively (<i>P</i> < 0.05). For the 2-month follow-up visits, there was no significant difference between the groups. Epithelium healing and stromal haze were comparable in the two groups without significant differences between them.</p><p><strong>Conclusion: </strong>Transepithelial photorefractive keratectomy with SPT yielded better short-term visual outcomes than traditional Transepithelial photorefractive keratectomy.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 3","pages":"337-341"},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620302/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142801784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epicapsular membrane - A surgical surprise.
Q3 Medicine Pub Date : 2024-10-24 eCollection Date: 2024-09-01 DOI: 10.4103/ojo.ojo_98_24
Jigyasa Sahu, Parul Jain
{"title":"Epicapsular membrane - A surgical surprise.","authors":"Jigyasa Sahu, Parul Jain","doi":"10.4103/ojo.ojo_98_24","DOIUrl":"10.4103/ojo.ojo_98_24","url":null,"abstract":"","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 3","pages":"408-410"},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620310/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142801866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Examining the competence of artificial intelligence programs in neuro-ophthalmological disorders and analyzing their comparative superiority.
Q3 Medicine Pub Date : 2024-10-24 eCollection Date: 2024-09-01 DOI: 10.4103/ojo.ojo_19_24
Eyupcan Sensoy, Mehmet Citirik

Background: This study aims to evaluate the knowledge levels of chat generative pretrained transformer (ChatGPT), Bing, and Bard programs, which are three different artificial intelligence chatbots offered to the market free of charge by various manufacturers, regarding neuro-ophthalmological diseases, to examine their usability, and to investigate the existence of their superiority to each other.

Materials and methods: Forty questions related to neuro-ophthalmological diseases were obtained from the study questions' section of the American Academy and Ophthalmology 2022-2023 Basic and Clinical Science Course Neuro-ophthalmology Book. The questions were posed to the ChatGPT, Bing, and Bard artificial intelligence chatbots. The answers were evaluated as correct or incorrect. The statistical relationship between the correct and incorrect answer rates offered by the artificial intelligence programs was tested.

Results: The correct answer rates were given by the artificial intelligence programs to the questions asked: ChatGPT - 52.5%; Bing - 55%; and Bard - 65%. There was no statistically significant difference between the correct answer rates of the three artificial intelligence programs (P = 0.489, Pearson's Chi-square test).

Conclusion: Although information about neuro-ophthalmological diseases can be accessed quickly and accurately using up-to-date artificial intelligence programs, the answers given may not always be correct. Care should always be taken when evaluating the answers to the questions.

{"title":"Examining the competence of artificial intelligence programs in neuro-ophthalmological disorders and analyzing their comparative superiority.","authors":"Eyupcan Sensoy, Mehmet Citirik","doi":"10.4103/ojo.ojo_19_24","DOIUrl":"10.4103/ojo.ojo_19_24","url":null,"abstract":"<p><strong>Background: </strong>This study aims to evaluate the knowledge levels of chat generative pretrained transformer (ChatGPT), Bing, and Bard programs, which are three different artificial intelligence chatbots offered to the market free of charge by various manufacturers, regarding neuro-ophthalmological diseases, to examine their usability, and to investigate the existence of their superiority to each other.</p><p><strong>Materials and methods: </strong>Forty questions related to neuro-ophthalmological diseases were obtained from the study questions' section of the American Academy and Ophthalmology 2022-2023 Basic and Clinical Science Course Neuro-ophthalmology Book. The questions were posed to the ChatGPT, Bing, and Bard artificial intelligence chatbots. The answers were evaluated as correct or incorrect. The statistical relationship between the correct and incorrect answer rates offered by the artificial intelligence programs was tested.</p><p><strong>Results: </strong>The correct answer rates were given by the artificial intelligence programs to the questions asked: ChatGPT - 52.5%; Bing - 55%; and Bard - 65%. There was no statistically significant difference between the correct answer rates of the three artificial intelligence programs (<i>P</i> = 0.489, Pearson's Chi-square test).</p><p><strong>Conclusion: </strong>Although information about neuro-ophthalmological diseases can be accessed quickly and accurately using up-to-date artificial intelligence programs, the answers given may not always be correct. Care should always be taken when evaluating the answers to the questions.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 3","pages":"348-351"},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620313/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142801874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A retrospective study of the incidence, patterns, and risk factors of retinopathy of prematurity in infants with birth weight >1500 g in a South Indian tertiary care hospital.
Q3 Medicine Pub Date : 2024-10-24 eCollection Date: 2024-09-01 DOI: 10.4103/ojo.ojo_35_24
Vishalakshi Bhat, Shankargouda H Patil

Objective: The objective of the study was to determine the incidence, patterns, and risk factors for the development of retinopathy of prematurity (ROP) in infants weighing >1500 g at birth.

Materials and methods: A retrospective analysis was done of the ROP screening records between April 2019 and March 2022. All the infants with birth weight >1500 g who underwent ROP screening were included. Data collected included demographic details, details of the risk factors (respiratory distress syndrome [RDS], hypoxia, anemia, septicemia, patent ductus arteriosus, congenital heart disease [CHD], i.e., atrial septal defects or ventricular septal defects, and multiple gestations), and ocular examination findings. Statistical analyses included calculation of mean, range, Chi-square test, and bivariate logistic regression for associations of risk factors with ROP.

Results: ROP was noted in 16.6% of the 336 eyes of 168 infants. The mean birth weight and mean gestational age (GA) of the infants were 1850 ± 33 g and 33.33 weeks ± 1.71 weeks, respectively. Eighteen eyes (32.1%) had Stage I, 17 eyes (30.35%) had Stage II, and 11 eyes (19.64%) had Stage III ROP in Zone II. Aggressive ROP was seen in 8 eyes (14.28%) and stage 5 ROP in two eyes (0.59%). Male gender, GA, CHD, and RDS showed a statistically significant association with the development of ROP in these infants.

Conclusion: ROP was seen in 16.66% of our subjects. Treatment was required in 6.25% of infants. Risk factors for the development of ROP were low gestational age, male gender, the presence of RDS, and congenital heart disease.

{"title":"A retrospective study of the incidence, patterns, and risk factors of retinopathy of prematurity in infants with birth weight >1500 g in a South Indian tertiary care hospital.","authors":"Vishalakshi Bhat, Shankargouda H Patil","doi":"10.4103/ojo.ojo_35_24","DOIUrl":"10.4103/ojo.ojo_35_24","url":null,"abstract":"<p><strong>Objective: </strong>The objective of the study was to determine the incidence, patterns, and risk factors for the development of retinopathy of prematurity (ROP) in infants weighing >1500 g at birth.</p><p><strong>Materials and methods: </strong>A retrospective analysis was done of the ROP screening records between April 2019 and March 2022. All the infants with birth weight >1500 g who underwent ROP screening were included. Data collected included demographic details, details of the risk factors (respiratory distress syndrome [RDS], hypoxia, anemia, septicemia, patent ductus arteriosus, congenital heart disease [CHD], i.e., atrial septal defects or ventricular septal defects, and multiple gestations), and ocular examination findings. Statistical analyses included calculation of mean, range, Chi-square test, and bivariate logistic regression for associations of risk factors with ROP.</p><p><strong>Results: </strong>ROP was noted in 16.6% of the 336 eyes of 168 infants. The mean birth weight and mean gestational age (GA) of the infants were 1850 ± 33 g and 33.33 weeks ± 1.71 weeks, respectively. Eighteen eyes (32.1%) had Stage I, 17 eyes (30.35%) had Stage II, and 11 eyes (19.64%) had Stage III ROP in Zone II. Aggressive ROP was seen in 8 eyes (14.28%) and stage 5 ROP in two eyes (0.59%). Male gender, GA, CHD, and RDS showed a statistically significant association with the development of ROP in these infants.</p><p><strong>Conclusion: </strong>ROP was seen in 16.66% of our subjects. Treatment was required in 6.25% of infants. Risk factors for the development of ROP were low gestational age, male gender, the presence of RDS, and congenital heart disease.</p>","PeriodicalId":19461,"journal":{"name":"Oman Journal of Ophthalmology","volume":"17 3","pages":"357-361"},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11620298/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142801240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Oman Journal of Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1